Anemocyte is heading to Boston!

Anemocyte is heading to Boston!

We’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston Convention & Exhibition Center.

This premier event brings together over 20,000 biotech leaders from around the globe, offering a dynamic platform for innovation, collaboration, and advancement in the life sciences.

The convention features more than 135 sessions across 18 focus areas, including:

  • AI and Digital Health
  • Cell and Gene Therapy and Genome Editing
  • Biomanufacturing
  • Business Development and Investment
  • Next Generation
  • Biotherapeutics
  • Patient Advocacy
  • Regulatory Innovation
  • Environmental
  • Sustainability
  • Emerging Opportunities in Global Markets
  • Oncology
  • Orphan and Rare Disease
  • Diagnostics and Personalized Medicine
  • Value, Patient Access and Reimbursement
  • Intellectual Property and Legal Landscape
  • Diversity and Opportunity
  • Brain Health
  • Infectious Disease and Vaccines
  • Translational Research

Anemocyte's talk

As part of our presence at the convention, Anemocyte will deliver a presentation within the Italian Pavilion, organized by ICE – Italian Trade Agency, on June 16 at 5:00 PM. 

This intervention will highlight our commitment to innovation in advanced therapies and the global biotech ecosystem.

Meet us: booth 1953A, Exhibit Hall B2.

1200 900 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961